Oracle Investment Management as of June 30, 2023
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 29 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pacific Biosciences of California (PACB) | 19.8 | $27M | 2.0M | 13.30 | |
| Quidel Corp (QDEL) | 15.0 | $20M | 246k | 82.86 | |
| Biohaven (BHVN) | 10.5 | $14M | 598k | 23.92 | |
| Opko Health (OPK) | 6.8 | $9.2M | 4.2M | 2.17 | |
| Surgery Partners Call Call Option | 5.8 | $7.9M | 175k | 44.99 | |
| Pacific Biosciences Calif In Call Call Option | 5.0 | $6.9M | 515k | 13.30 | |
| Quidelortho Corp Call Call Option | 5.0 | $6.8M | 82k | 82.86 | |
| Mirati Therapeutics | 4.1 | $5.5M | 153k | 36.13 | |
| Genedx Holdings Corp Com Cl A (WGS) | 3.8 | $5.2M | 866k | 5.96 | |
| Agenus Com New (AGEN) | 3.6 | $4.9M | 3.1M | 1.60 | |
| Blueprint Medicines Corp Call Call Option | 3.0 | $4.1M | 65k | 63.20 | |
| BioCryst Pharmaceuticals (BCRX) | 2.9 | $3.9M | 556k | 7.04 | |
| Forian Ord (FORA) | 2.5 | $3.3M | 1.4M | 2.45 | |
| Blueprint Medicines (BPMC) | 1.9 | $2.6M | 41k | 63.20 | |
| Ardelyx (ARDX) | 1.7 | $2.4M | 700k | 3.39 | |
| Immutep Sponsored Ads (IMMP) | 1.4 | $1.9M | 894k | 2.11 | |
| Mirati Therapeutics Call Call Option | 1.3 | $1.8M | 50k | 36.13 | |
| Accelr8 Technology | 0.9 | $1.2M | 1.5M | 0.81 | |
| Biohaven Call Call Option | 0.9 | $1.2M | 49k | 23.92 | |
| Omega Therapeutics Common Stock (OMGA) | 0.8 | $1.1M | 197k | 5.60 | |
| Fibrogen Call Call Option | 0.6 | $748k | 277k | 2.70 | |
| Biogen Idec (BIIB) | 0.5 | $687k | 2.4k | 284.85 | |
| Surgery Partners (SGRY) | 0.5 | $675k | 15k | 44.99 | |
| Vertex Energy (VTNR) | 0.5 | $628k | 100k | 6.25 | |
| Palantir Technologies Cl A (PLTR) | 0.4 | $563k | 37k | 15.33 | |
| Opko Health Call Call Option | 0.4 | $514k | 237k | 2.17 | |
| Proshares Tr Ultrapro Qqq (TQQQ) | 0.3 | $414k | 70k | 5.92 | |
| Dermtech Ord ord (DMTK) | 0.1 | $124k | 48k | 2.60 | |
| Mink Therapeutics (INKT) | 0.1 | $106k | 51k | 2.10 |
